1. Introduction
===============

Type 2 diabetes mellitus (T2DM) incidence is increasing in China at an alarming rate, imposing a considerable burden on public health. The latest epidemiological survey showed that the diabetes prevalence in individuals above 20 years old was 9.7%, with a prediabetes prevalence reaching 15.5% in the Chinese population.^\[[@R1]\]^ The common acute complications of T2DM include diabetic ketoacidosis, hyperglycemia, hypoglycemia, and diabetic coma. The major chronic complications include microangiopathies (ie, diabetic cardiomyopathy, neuropathy, nephropathy, and retinopathy), macrovascular diseases (ie, coronary artery and peripheral vascular diseases, and stroke), diabetic foot, necrosis, and gangrene. Atherosclerosis is a progressive disease and its clinical consequences are potentially life-threatening.

As a frequently encountered macrovascular complication of diabetes, lower extremity atherosclerotic disease (LEAD) counts among the main factors causing foot ulceration and amputation,^\[[@R2]\]^ which lead to markedly reduced quality of life.^\[[@R3]\]^ Moreover, LEAD constitutes an important indicator of atherosclerotic disease burden, and is associated with high mortality from cardiovascular and cerebrovascular causes.^\[[@R4]\]^ Peripheral artery disease is characterized by occlusion of lower-extremity arteries,^\[[@R5]\]^ which results in functional impairment,^\[[@R6]\]^ disability,^\[[@R7]\]^ foot ulceration, and lower-extremity amputation.^\[[@R8]\]^ Diabetic patients are 15 times more likely to suffer from lower-extremity amputation than people without diabetes.^\[[@R9]\]^ Epidemiological data indicated that the incidence of diabetic LEAD in the Asian population is different from that obtained for other populations around the world. Umuerri and Obasohan^\[[@R10]\]^ reported a LEAD prevalence of 35.6% in Nigeria. Another study assessing patients in Costa Rica found an incidence rate for diabetic LEAD of 6.02 per 1000 person-years.^\[[@R11]\]^ Although no clear data regarding individuals with diabetic LEAD in China are available, local epidemiological investigations and hospital surveys indicated incidence rates for diabetic LEAD of 5.2% to 23.8% among individuals above 50 years of age.^\[[@R12]--[@R14]\]^

Timely detection and treatment of LEAD are essential in preventing amputation, morbidity, and mortality of diabetic patients. Although LEAD represents an independent predicting factor of cardiovascular and cerebrovascular ischemia, its diagnosis and treatment remain suboptimal.^\[[@R15]\]^ Hence, diabetic patients need to identify lower-limb atherosclerosis at its early stage.

The association of LEAD with different risk factors of atherosclerosis in T2DM needs continuous investigation. Several risk factors of LEAD have been identified, including age, female sex, years of diabetes, elevated glycosylated hemoglobin (HbA1c), retinopathy, waist-to-hip ratio (WHR), triglyceride (TG) levels, and hypertension.^\[[@R16]--[@R19]\]^ A previous study showed that blood lipid, body mass index, smoking, and type of antidiabetic treatment were not associated with LEAD in diabetic patients.^\[[@R19]\]^ However, conventional risk factors for atherosclerosis such as smoking, hypertension, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and TG could not be ignored as risk factors. Hence, this study aimed to identify the risk factors associated with LEAD in the Chinese diabetic population.

In previous studies, diagnosis of peripheral artery disease mostly relied on the ankle brachial index.^\[[@R20]\]^ However, color Doppler ultrasound has many advantages over pressure measurements in that it can both diagnose and localize arterial lesions accurately. Moreover, color Doppler ultrasound correctly differentiates iliac from femoro-popliteal disease, with an overall diagnostic accuracy of 90% in the femoral and popliteal vessels for both occlusion and stenosis.^\[[@R21]\]^ Hence, in the present study, LEAD was evaluated by color Doppler ultrasonography to identify the risk factors associated with LEAD in Chinese individuals with T2DM.

2. Patients and methods
=======================

2.1. Patients
-------------

In this case-control study, inpatients with T2DM (n = 1289) admitted at the Department of Endocrinology, Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital, between January 2008 and December 2009, were enrolled. The subjects were chosen based on World Health Organization guidelines on diagnosis and classification of diabetes mellitus, 1999.^\[[@R22]\]^ There were 746 males and 543 females averagely aged 61 (22--90) years, with a median T2DM course of 6 (0.01, 40) years. Patients with autoimmune disease, acute infections, acute complication of diabetes mellitus, primary renal disease, active stage of renal stone, and other serious diseases were excluded. In addition, patients receiving treatment with glucocorticoids and immuno-suppressors were also excluded. This study was approved by the Ethics Committee of Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital. Signed informed consent was provided by each participant, and all principles of the Declaration of Helsinki were applied.

2.2. Determination of variables
-------------------------------

Clinical and demographic data of patients, including age, sex, diabetes duration, body mass index, WHR, microalbuminuria (MAU), glomerular filtration rate (GFR), creatinine, and history of hypertension, dyslipidemia, coronary heart disease (CHD), and cerebral vascular disease (CVD) were collected. Patients' medical data at admission included waist circumference, hip circumference, and blood pressure assessments. WHR was calculated as waist circumference/hip circumference. Hypertension was reflected by diastolic blood pressure ≥90 mm Hg, systolic blood pressure ≥140 mm Hg, or current use of antihypertensive medication. Dyslipidemia was determined by any of the following criteria: elevated TC ≥6.22 mmol/L and/or TG ≥2.27 mmol/L, elevated low-density lipoprotein cholesterol (LDL-C) ≥4.14 mmol/L, and decreased HDL-C \<1.04 mmol/L (according to the American National Cholesterol Education Program, Adult Treatment Panel III),^\[[@R23]\]^ or patients under lipid-lowering drugs.^\[[@R24]\]^ CHD was considered with a history of ischemia or abnormal electrocardiogram findings. CVD was considered with a history of ischemia or stroke. The diagnosis of diabetic peripheral neuropathy (DPN) was according to the Standards of Medical Care in Diabetes, 2008, published by the American Diabetes Association.^\[[@R25]\]^ The diagnosis of diabetic retinopathy (DR) was based on the International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales.^\[[@R26]\]^ GFR was assessed by radionuclide renal dynamic imaging (modified Gate method) after intravenous injection of ^99^mTc-diethylene-triamine-penta-acetic acid and using a Siemens Signature e.cam single photon emission computed tomography (Siemens, Erlangen, Germany).

2.3. Laboratory tests
---------------------

Fasting blood specimens were collected before breakfast the day after admission for fasting plasma glucose (FPG), HbA1c, uric acid (UA), TC, TG, LDL-C, and HDL-C assessment. Plasma glucose levels were determined by the glucose oxidase method (Automatic Biochemistry Analyzer; Beckman Coulter). Serum lipid components and renal function parameters were assessed by routine procedures on an AutoAnalyzer (Hitachi 7600--020; Hitachi, Tokyo, Japan). HbA1c was estimated by high-performance liquid chromatography on a HLC-723G7 analyzer (Tosoh Corporation, Japan).

2.4. Determination of LEAD
--------------------------

Color duplex ultrasonography was performed by 3 experienced sonographers using an ACUSON Sequoia 512 ultrasound system (Siemens, Erlangen, Germany), with a 5 to 13-MHz linear transducer, based on a previously published technique.^\[[@R27]\]^ Femoral intima-media thickness (FIMT) values for both sides were determined as the distance from the leading edge of the lumen-intima echo to that of the media-adventitia echo. LEAD was considered with the observation of a focal structure intruding in the arterial lumen by 0.5 mm or ≥50% thicker than the surrounding vessel wall, or intima-media thickness (IMT) \>1.5 mm in any lower-limb arteries according to the Mannheim IMT consensus.^\[[@R28]\]^ In subgroup analysis, patients with T2DM and LEAD were categorized into 2 groups: LEAD+A (1%--49% diameter of lower-limb arteries reduction) and LEAD+B (≥50% diameter reduction).

2.5. Statistical analysis
-------------------------

The statistical analysis was performed using SPSS 18.0 (IBM, Armonk, NY). Normally distributed quantitative variables were presented as mean ± standard deviation (SD) and compared using independent-samples *t* test; data with non-normal distribution were presented as median (range) and evaluated using Mann--Whitney *U* test. Categorical data were expressed as frequency and compared using the chi-square test. Multivariate logistic regression analysis was performed to determine the odds ratios (OR) and 95% confidence intervals (95% CIs) using the enter method. Independent variables with *P* \< 0.05 in univariate analyses were entered in the multivariate logistic regression. *P* \< 0.05 was considered statistically significant.

3. Results
==========

3.1. Comparison of clinical characteristics among different LEAD groups
-----------------------------------------------------------------------

Compared with the LEAD− group, patient age, course of diabetes mellitus, WHR, serum creatinine, HDL-C level, MAU, hypertension, systolic blood pressure, CHD, and CVD in the LEAD+ group were significantly higher, whereas the levels of FPG, GFR, and TG were significantly lower (all *P* \< 0.05). Sex, BMI, level of HbA1C, UA, LDL-C, TC, diastolic pressure, rate of dyslipidemia, DR, and DPN were not significantly different (all *P* \> 0.05) (Table [1](#T1){ref-type="table"}). In subgroup analysis, compared with the LEAD+A group, patient age, course of diabetes mellitus, WHR, UA levels, serum creatinine, and systolic blood pressure in the LEAD+B group were significantly higher, whereas GFR, hypertension rate, DR, CHD, and CVD were markedly lower (all *P* \< 0.05). Sex, BMI, level of FPG, HbA1C, MAU, HDL-C, LDL-C, TC, TG, diastolic pressure, dyslipidemia, and DPN were not significantly different (all *P* \> 0.05) (Table [1](#T1){ref-type="table"}).
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3.2. Multivariate logistic regression analysis of independent factors associated with LEAD in patients with T2DM
----------------------------------------------------------------------------------------------------------------

Independent variables including age, diabetes duration, WHR, FPG, creatinine, UA, MAU, GFR, dyslipidemia, and hypertension were evaluated using a multivariate logistic regression model. GFR (OR 0.991, 95% CI 0.986--0.997, *P* = 0.003), diabetes duration (OR 1.055, 95% CI 1.026--1.084, *P* \< 0.001), age (OR 1.123, 95% CI 1.104--1.142, *P* \< 0.001), and UA (OR 1.002, 95% CI 1.000--1.004, *P* = 0.031) were independently associated with LEAD in patients with T2DM (Table [2](#T2){ref-type="table"}).
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Multivariate logistic regression analysis of independent factors associated with lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus.
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3.3. Multivariate logistic regression analysis of independent factors associated with lesion severity in patients with T2DM and LEAD
------------------------------------------------------------------------------------------------------------------------------------

Independent variables including age, diabetes duration, WHR, creatinine, UA, GFR, hypertension, and DR were evaluated using a multivariate logistic regression model. As shown in Table [3](#T3){ref-type="table"}, age (OR 1.078, 95% CI 1.048--1.109, *P* \< 0.001) and GFR (OR 0.985, 95% CI 0.975--0.994, *P* = 0.002) were independently associated with the severity of arterial lesions in patients with T2DM and LEAD (Table [3](#T3){ref-type="table"}).
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Multivariate logistic regression analysis of independent factors associated with the severity of the lesion in patients with T2DM and lower extremity atherosclerotic disease.
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4. Discussion
=============

In the present study, age, GFR, duration of diabetes, and UA were found to be independent risk factors of LEAD in patients with T2DM. In addition, age and GFR were independently associated with lesion severity in patients with T2DM and LEAD.

The prevalence of LEAD is overtly higher in the diabetic population than in nondiabetic individuals, and LEAD substantially increases the risk of cardiovascular and cerebrovascular events such as myocardial infarction and stroke.^\[[@R29],[@R30]\]^ Furthermore, cardiovascular and cerebrovascular event rates are greater in diabetic individuals, with atherosclerosis compared with comparable nondiabetic populations.^\[[@R31]\]^ Diabetic patients with peripheral arterial disease comorbidity are at higher risk of lower-extremity amputation than those without diabetes.^\[[@R32]\]^ Hence, timely detection and treatment of LEAD is essential in preventing amputation and death in diabetic patients.

The development of LEAD in T2DM involves many aspects, among which patient age and course of diabetes are risk factors.^\[[@R33]--[@R35]\]^ In agreement, the present study also showed that the risk factors for LEAD in T2DM included age and diabetes duration. The possible reasons could be as follows: the incidence of arteriosclerosis increases with age; and prolonged disease course indicates chronic hyperglycemia, and extended chronic hyperglycemia contributes to protein glycation and yields advanced glycation end products, and also oxygen free radicals, which damage vascular endothelial cells and promote arteriosclerosis, and also plaque formation.

In the present study, FPG was lower in patients with LEAD, but not identified as an independent predicting factor of LEAD, in disagreement with previous reports.^\[[@R34],[@R35]\]^ The possible reasons could be that the vast majority of patients assessed here were hospitalized for severely poor glycemic control, and FPG levels at admission might differ from the values obtained in the general population.

Hyperuricemia is a well-known risk factor for cardiovascular diseases.^\[[@R36],[@R37]\]^ Indeed, Chuengsamarn et al^\[[@R38]\]^ found that elevated UA levels are significantly associated with diabetes-related chronic micro/macrovascular complications. Therefore, UA levels monitoring has a prognostic value for chronic micro/macrovascular complications in diabetic patients. Zhang et al^\[[@R39]\]^ investigated 2174 T2DM individuals and found serum UA levels to be an independent risk factor for LEAD in female diabetic patients. These reports corroborated our findings that serum UA levels were higher in diabetic patients with LEAD, and represented a significant predicting factor for LEAD. In the present study, hypertension rate, CHD, and cerebral infarction rate were markedly higher in diabetic patients with LEAD than in those without LEAD, in accordance with previously published data.^\[[@R3],[@R34],[@R40]\]^

There is a certain correlation between macroangiopathy and microangiopathy. Yu et al^\[[@R41]\]^ found that LEAD is related to diabetic nephropathy in T2DM patients. Yap et al^\[[@R42]\]^ demonstrated that GFR decrease is an independent risk factor for diabetic LEAD regardless of proteinuria level, with LEAD incidence in the abnormal GFR group obviously increased compared with that of the normal GFR group. Furthermore, higher incidence of LEAD was evidenced with a more apparent decline of GFR. In the present study, logistic regression analysis showed that UA and GFR were independent risk factors for diabetic LEAD. Dysfunction of endothelial cells in patients with diabetic nephropathy may account for these findings. The dysfunction not only exists in kidney capillaries, but also in systemic vascular beds. Plasma proteins can permeate through damaged endothelial cells and cause changes in the endarterium, further promoting the development of atherosclerosis.

In the present study, subgroup analysis results showed that age and GFR were independent risk factors for lesion severity in T2DM patients with LEAD. In a previous study, age was found to be an independent risk factor for the severity of peripheral arterial disease.^\[[@R43]\]^

A number of factors are involved in the development of LEAD and were not evaluated in the present study. Indeed, recent reports demonstrated the role of infectious diseases in peripheral artery disease. Indeed, it was suggested that periodontal pathogens might translocate from subgingival microbiota to the bloodstream, further progressing to atheromatous plaques in peripheral arteries.^\[[@R44]\]^ In addition, *Salmonella* infects peripheral or visceral arteries, and most commonly the abdominal aorta,^\[[@R45]\]^ and multiple sexually transmitted diseases such as Syphilis and acquired immunodeficiency syndrome (AIDS) were shown to be involved in vascular diseases.^\[[@R46],[@R47]\]^ However, this factor was not evaluated in the present study because of difficulties in identifying all infections, especially those without overt clinical signs, and to distinguish acute from chronic infections. Additional studies are necessary to assess this issue.

A few limitations of the present study should be mentioned. First, we could not analyze the progression of atherosclerotic lesions. In addition, the study was carried out in a single center, with a small sample size. Finally, other confounding factors of LEAD were not excluded. Therefore, additional larger clinical studies are warranted to confirm the risk factors of LEAD reported in this study.

5. Conclusions
==============

Lower extremity atherosclerotic disease in T2DM patients is a chronic pathological process caused by multiple factors. Risk factors for LEAD include age, disease course, UA levels, and GFR. Patients with T2DM, high UA levels, and declined GFR should be considered a high-risk group for LEAD.
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